Alphabody Polypeptides for Intracellular Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Macromolecules, such as polypeptides and nucleic acids, face difficulties in crossing cellular membranes to reach intracellular targets due to unfavorable biological and physicochemical properties, limiting their therapeutic and diagnostic applications.
Innovation Solution
Development of Alphabody polypeptides with a positively charged internalization region, comprising at least six positively charged amino acid residues, that can penetrate cell membranes and specifically bind to intracellular targets, enhancing their stability and functionality within cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If macromolecules are used as therapeutic agents to target intracellular components, then binding specificity and stability are improved, but the ability to cross cellular membranes deteriorates
Solution Approach 1:
The polypeptide is divided into distinct functional segments: an internalization region (with positively charged residues for membrane penetration) and a binding region (for specific target recognition). This segmentation allows each region to independently perform its specialized function, resolving the contradiction between membrane permeability and binding specificity
Solution Approach 2:
Different regions of the polypeptide are assigned different local properties: the internalization region contains clustered positively charged amino acids (lysine, arginine) for electrostatic interaction with membranes, while the binding region maintains the structural characteristics needed for specific target binding. This local differentiation enables simultaneous optimization of both membrane crossing and specific binding
2Ease of operation
If delivery vehicles are used to facilitate internalization, then cellular uptake is improved, but accumulation in lysosomes and degradation deteriorates
Solution Approach 1:
The internalization region acts as an intermediary that mediates membrane crossing through electrostatic interactions, but is designed to release the bound effector molecule after internalization. This allows the effector to be delivered into the cytoplasm without being trapped in endocytic pathways leading to lysosomal degradation
Solution Approach 2:
The polypeptide uses specific parameter changes in charge distribution (clustered positive charges in internalization region vs. neutral/polar charges in binding region) and structural organization (amphipathic helices) to switch between membrane-binding mode and effector-release mode, ensuring delivery to the correct intracellular compartment while avoiding degradation pathways
3Ease of operation
If polypeptides are designed with positively charged regions for internalization, then membrane penetration is improved, but structural stability may deteriorate
Solution Approach 1:
The polypeptide combines different types of amino acid residues with complementary properties: positively charged residues (lysine, arginine) for membrane interaction, hydrophobic residues for structural core formation, and polar residues for binding specificity. This composite composition allows the structure to simultaneously achieve membrane penetration capability and structural stability
Solution Approach 2:
The internalization region forms amphipathic alpha-helical structures with specific curvature and geometry that facilitate membrane interaction while maintaining structural integrity. The helical configuration provides both the positive charge presentation needed for membrane binding and the structural stability required to resist degradation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Alphabody polypeptides effectively enter cells and maintain stability, enabling targeted modulation of intracellular processes and addressing previously 'undruggable' protein targets, thereby expanding therapeutic options for various diseases.
Implementation Method 1
capable of being internalized into a cell through the presence of at least one positively charged internalization region
Data Source
AI summary
Provided herein are polypeptides that are capable of crossing the cellular membrane and entering into the intracellular environment, which polypeptides are suitable for use in prophylactic, therapeutic or diagnostic applications as well as in screening and detection. Nucleic acids encoding such polypeptides; methods for preparing such polypeptides, host cells expressing or capable of expressing such polypeptides, compositions, and in particular pharmaceutical compositions, that comprise such polypeptides, in particular for prophylactic, therapeutic or diagnostic purposes are also provided.


